Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/60026
Full metadata record
DC FieldValueLanguage
dc.creatorFlávia Sirotheau Corrêa Pontespt_BR
dc.creatorWladimir Gushiken de Campospt_BR
dc.creatorMilena Coelho Fernandes Caldatopt_BR
dc.creatorRegina Matsunaga Martinpt_BR
dc.creatorFelipe Paiva Fonsecapt_BR
dc.creatorHélder Antônio Rebelo Pontespt_BR
dc.creatorMárcio Ajudarte Lopespt_BR
dc.creatorLucas Lacerda de Souzapt_BR
dc.creatorDiogo Rezendept_BR
dc.creatorAlan Roger dos Santos-Silvapt_BR
dc.creatorJacks Jorgept_BR
dc.creatorWagner Gomes da Silvapt_BR
dc.creatorFábio Ramôa Pirespt_BR
dc.creatorAndré Caroli Rochapt_BR
dc.date.accessioned2023-10-25T19:14:58Z-
dc.date.available2023-10-25T19:14:58Z-
dc.date.issued2018-01-
dc.citation.volume125pt_BR
dc.citation.spage31pt_BR
dc.citation.epage43pt_BR
dc.identifier.doihttps://doi.org/10.1016/j.oooo.2017.09.011pt_BR
dc.identifier.issn22124403pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/60026-
dc.description.resumoObjective: To describe the oral and maxillofacial manifestations of patients diagnosed with chronic kidney disease-mineral and bone disorders. Study design: Over a 13-year period, clinicopathologic data of patients diagnosed with CKD-MBD who had oral and maxillofacial alterations were retrieved from the files of 4 Brazilian institutions. Data included clinical, radiographic, microscopic, and biochemical findings; treatment employed; and follow-up status. Results: Twenty-one cases were identified, with 13 patients diagnosed as brown tumor of hyperparathyroidism (BTH) and 8 as osteitis fibrosa/renal osteodystrophy (OF/RO) (4 of them clinically consistent with Sagliker syndrome). The mean age was 32.7 years, and the mandible was the most affected site (42.8%). OF/RO had an ill-defined "ground glass" radiographic appearance, and BTH produced well-defined radiolucent images. Biochemically the following mean values were obtained: parathormone 1511.07 pg/mL, calcium 9.25 mg/dL, phosphorus 5.19 mg/dL, alkaline phosphatase 941.55 U/L, urea 125.42 mg/dL, and creatinine 7.14 mg/dL. Treatment comprised vitamin D and calcium intake, parathyroidectomy, hemodialysis, renal transplantation, and local surgery. During follow-up, 5 patients with BTH were free of lesions, whereas 2 affected by OF/RO/Sagliker syndrome died. Conclusions: Oral and maxillofacial manifestations of BTH and OF/RO are uncommon, but they can be associated with an important life-threatening scenariopt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentFAO - DEPARTAMENTO DE CLÍNICApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofOral Surgery, Oral Medicine, Oral Pathology and Oral Radiologypt_BR
dc.rightsAcesso Restritopt_BR
dc.subjectacess restrito Oral and maxillofacial manifestations of chronic kidney disease-mineral and bone disorder: a multicenter retrospective study fao clinica busca dia 12 do 09 2023 assunto tumorpt_BR
dc.subject.otherChronic kidney disease-mineral and bone disorderpt_BR
dc.subject.otherMouthpt_BR
dc.subject.otherMaxillapt_BR
dc.subject.otherFacept_BR
dc.subject.otherMandiblept_BR
dc.subject.otherDiseasept_BR
dc.titleOral and maxillofacial manifestations of chronic kidney disease-mineral and bone disorder: a multicenter retrospective studypt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://www.sciencedirect.com/science/article/pii/S2212440317310672?via%3Dihubpt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.